TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

AstraZeneca Doubles Down On US Biologics Buildout As Drug Discovery Partnership Grows

Benzinga Logo Benzinga • •By Vandana Singh
AstraZeneca Doubles Down On US Biologics Buildout As Drug Discovery Partnership Grows

AstraZeneca expands its biologics manufacturing in Maryland with a $2 billion investment and strengthens its drug discovery partnership with Harbour BioMed, focusing on developing next-generation biotherapeutics in immunology and oncology.

Insights
KO   positive

Mentioned as one of top 5 accounts increasing advertising spend with Lamar Advertising


AZN   positive

Investing $2 billion in manufacturing expansion, creating 2,600 jobs, expanding biologics capacity, and extending strategic partnership with Harbour BioMed